ArticleEJHaem2020
Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma.
Louisa Shackleton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it